Bariatric Surgery CandidateObesity, MorbidObesity, Adolescent
Investigational drug(s) / intervention(s)
Laparoscopic adjustable gastric banding
Laparoscopic adjustable gastric banding: Weight-loss surgery, with the use of gastric banding
Study summary
Obesity affects 3%-4% of the pediatric population and leads to cardiac mortality during adult life. Bariatric surgery is the best treatment for weight loss and preventing obesity associated comorbidities in adults, but its applications and safety are yet to be defined for adolescents.
Eligibility
Sex
ALL
Min age
14 Years
Max age
20 Years
Healthy volunteers
No
Inclusion Criteria:
* Patients aged 14-20 years of age and asking for bariatric surgery
* BMI \>= 40 Kg.m-2 or \>= 35 Kg.m-2 with major obesity-related comorbidities (hypertension, diabetes, sleep apnea, etc...)
Exclusion Criteria:
* An unstable psychiatric disorder
* Bariatric surgery anesthesic contraindications
* Having not completed a minimum of six months of the pre operative program
* Lack of consent from the patient or the patient's relatives.
Primary outcome measure(s)
Change of weight parameters at 2 years compared to preoperative baseline — 2 years Evaluation of weight loss by weight (Kg), body mass index (BMI, Kg.m-2) and excess body weight (EBWL, %) changes
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.